Ethnopharmacology of Q'eqchi' Maya antiepileptic and anxiolytic plants: effects on the GABAergic system.
BACKGROUND
The Q'eqchi' Maya possess a large selection of plants to treat neurological disorders, including epilepsy and susto (fright), a culture-bound illness related to anxiety disorders.


OBJECTIVE
To investigate the activity of antiepileptic and anxiolytic plants in the GABAergic system, and determine if there is a pharmacological basis for plant selection.


METHODS
Ethanol extracts of 34 plants were tested in vitro for their ability to inhibit GABA-transaminase (GABA-T) or bind to the GABA(A)-benzodiazepine (BZD) receptor, two principal drug targets in epilepsy and anxiety. Pharmacological activity was correlated with relative frequency of use, based on informant consensus.


RESULTS
Ten plants showed greater than 50% GABA-T inhibition at 1mg/ml, while 23 showed greater than 50% binding to the GABA(A)-BZD receptor at 250 microg/ml. Piperaceae, Adiantaceae and Acanthaceae families were highly represented and active in both assays. There was a significant positive correlation between GABA-T inhibition and relative frequency of use for epilepsy, and an even stronger correlation between GABA(A) binding and relative frequency of use for susto (fright).


CONCLUSIONS
Clearly, Q'eqchi' traditional knowledge of antiepileptic and anxiolytic plants is associated with the use of pharmacologically active plants. Based on the evidence, it is suggested that the mechanism of action for some traditionally used plants may be mediated through the GABAergic system.
Awad
Rosalie
R
Biology Department, University of Ottawa, Ontario, Canada.
Ahmed
Fida
F
Bourbonnais-Spear
Natalie
N
Mullally
Martha
M
Ta
Chieu Anh
CA
Tang
Andrew
A
Merali
Zul
Z
Maquin
Pedro
P
Caal
Francisco
F
Cal
Victor
V
Poveda
Luis
L
Vindas
Pablo Sanchez
PS
Trudeau
Vance L
VL
Arnason
John T
JT
D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors*; D014151:Anti-Anxiety Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000927:Anticonvulsants / Q000494:pharmacology* / Q000627:therapeutic use; D001007:Anxiety / Q000188:drug therapy; D001531:Belize; D004827:Epilepsy / Q000188:drug therapy*; D020834:Ethnopharmacology; D006801:Humans; D007197:Indians, Central American; D019684:Magnoliopsida; D008519:Medicine, Traditional; D008517:Phytotherapy; D010936:Plant Extracts / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D010946:Plants, Medicinal; D011963:Receptors, GABA-A / Q000378:metabolism*; D013634:Tannins / Q000032:analysis
D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D010936:Plant Extracts; D011963:Receptors, GABA-A; D013634:Tannins; D000612:4-Aminobutyrate Transaminase